Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Breast Lesion Localization Market by Type (Wire, Radioisotope (ROLL, RSL), Magnetic, Electromagnetic Localization), Usage (Breast Biopsy, Lumpectomy), End User (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers) - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
The landscape of the healthcare industry is poised for a significant transformation as the breast lesion localization market charts a remarkable trajectory. With a projected surge from USD 278.1 million in 2023 to a staggering USD 387.4 million by 2028, reflecting a commendable CAGR of 6.9%, this domain is set to reshape medical paradigms.
This growth is inherently linked to the soaring prevalence of breast cancer, bolstered by augmented breast cancer surgeries and the escalating geriatric population. The impetus for this surge is further fueled by heightened awareness regarding early breast cancer detection. Innovations in imaging technology and increased breast cancer screenings through mammography have unveiled non-palpable clinically occult breast lesions, necessitating precise perioperative localization.
Keenly responding to this demand, the realm of breast lesion localization equipment has witnessed rapid technological strides, aimed at enhancing patient safety, optimizing efficiency, and curbing healthcare costs. Despite this promising trajectory, challenges, such as regulatory approval uncertainties, loom as potential constraints.
Nonetheless, as the Asia Pacific region emerges as a growth nucleus with its vigorous CAGR during the forecast period, coupled with rising healthcare expenditures and an influx of awareness programs, the breast lesion localization market is poised to script a transformative narrative.
A spectrum of key players, including Hologic, Inc., Becton, Dickinson and Company, Merit Medical Systems, Leica Biosystems Nussloch GmbH, and Argon Medical Devices, stands at the forefront of this dynamic journey.
Breast biopsy segment accounted for a larger share of the breast lesion localization market
In 2022, the breast biopsy segment accounted for a larger share of the breast lesion localization market.
The large share of this segment can be attributed to the increasing number of patients opting for breast biopsies across the world, the increasing rate of non-palpable breast lesions detected in screening programs, the rising number of breast cancer screening programs, the growing incidence of breast cancer, and an increase in awareness of early cancer detection.
The electromagnetic localization will grow at the highest CAGR during the forecast period
Based on type, the electromagnetic localization segment is estimated to grow at the highest during the forecast period.
The high growth of this segment can be attributed to factors such as reduction in surgical delays, improved patient satisfaction, optimal surgical planning, and no need for radioactive components. A recent development in the field of breast localization methods is the emergence of technologically advanced localization methods, which use electromagnetic waves to localize breast lesions.
Premium Insights
- Rising Awareness About Breast Cancer and Increasing Government Initiatives Globally to Drive Market
- Wire Localization Held Largest Share of Asia-Pacific Breast Lesion Localization Market in 2022
- Asia-Pacific to Witness Highest Growth in Breast Lesion Localization Market During Forecast Period
- North America to Dominate Breast Lesion Localization Market Till 2028
- Emerging Economies to Register Higher Growth Rates During Study Period
Market Dynamics
Drivers
- Increasing Incidence of Breast Cancer
- Growth in Aging Population
- Increasing Awareness on Early Detection of Breast Cancer
Restraints
- Uncertainty in Regulatory Approval Procedures
Opportunities
- High Growth Potential in Emerging Economies
- Increasing Adoption of Technologically Advanced Localization Procedures
Challenges
- Shortage of Oncologists
Industry Insights
Industry Trends
- Electromagnetic Waves for Localization of Breast Lesions
- Radiofrequency Identification in Breast Lesion Localization
- Machine Learning Algorithms for Computer-Aided Breast Lesion Detection
- Impact of Economic Recession on Breast Lesion Localization Market
- Value Chain Analysis
- Reimbursement Analysis
Technology Analysis
- Key Technologies
- Wire-Guided Localization (Wl)
- Carbon Marking
- Radioguided Occult Lesion Localization (Roll)
- Radioactive Seed Localization (Rsl)
- Magnetic Seed Localization (Msl)
- Radiofrequency Reflector (Rfr)
- Complementary Technologies
- Mammography
- 3D Mammography or Tomosynthesis
- Magnetic Resonance Imaging
- Ultrasound
- Adjacent Technologies
- Computer Vision and Artificial Intelligence
Case Study Analysis
- Case Study 1: Estimating Market Size of Breast Lesion Localization Methods and Market Share Analysis for Key Products at Country Level
- Case Study 2: Estimating Market Size of Breast Biopsy and Market Share Analysis for Key Products at Country Level
Company Profiles
Key Players
- Hologic, Inc.
- Becton, Dickinson and Company
- Merit Medical Systems
- Leica Biosystems Nussloch GmbH
- Argon Medical Devices
- Laurane Medical LLC
- Endomagnetics Ltd. (Endomag)
- Intramedical Imaging, LLC
- Isoaid
- Surgiceye GmbH
Other Players
- Ranfac Corp.
- Mermaid Medical Group
- Izi Medical Products, LLC
- Matek Medikal
- Tsunami Medical Srl
- Bpb Medica
- Sirius Medical Systems B.V.
- Molli Surgical Inc.
- Sterylab S.R.L.
- Cp Medical
- Mdl Srl
- Biomedical Srl
- Elucent Medical
- Vigeo Srl
- Medax Medical Devices
For more information about this report visit https://www.researchandmarkets.com/r/6vfxaa
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
